Merck Ties Up With Zhifei To Distribute Gardasil In China, But What Happened To Sinopharm?
This article was originally published in PharmAsia News
Executive Summary
Merck has expanded its collaboration with Zhifei, its vaccine partner in China, by signing a three-year RMB 4.5 billion distribution deal for HPV vaccine Gardasil. But left unanswered is whether Merck will walk away from an intended partnership with Sinopharm it had previously emphasized.